- Zacks•9 hours ago
This week, several biotech companies were present at the annual meeting of the American Society of Hematology (ASH) with data on approved and pipeline candidates.
- Business Wire•21 hours agoEQUITY ALERT: Lundin Law PC Announces an Investigation of Agios Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Agios Pharmaceuticals, Inc. concerning possible violations of federal securities laws.
- Business Wire•yesterdaySHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Agios Pharmaceuticals, Inc. and Certain Officers and Directors
Levi & Korsinsky, LLP announces that it has commenced an investigation of Agios Pharmaceuticals, Inc. concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
AGIO : Summary for Agios Pharmaceuticals, Inc. - Yahoo Finance
Agios Pharmaceuticals, Inc. (AGIO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||46.01 x 100|
|Ask||46.60 x 400|
|Day's Range||45.74 - 48.22|
|52 Week Range||33.50 - 67.98|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-9.73|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|